Dow Down 0.18% Nasdaq Down 0.33%

Gilead Sciences Inc. (GILD)

-NasdaqGS
110.72 2.73(2.41%) Oct 29, 4:00PM EDT
|Pre-Market : 110.50 Down 0.22 (0.20%) 8:02AM EDT
Prev Close:113.45
Open:110.00
Bid:110.00 x 700
Ask:110.11 x 2400
1y Target Est:118.08
Beta:0.98
Next Earnings Date:N/A
Day's Range:108.00 - 113.43
52wk Range:63.50 - 114.13
Volume:21,173,035
Avg Vol (3m):14,365,100
Market Cap:167.37B
P/E (ttm):25.08
EPS (ttm):4.41
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Related Video

Comparison

Symbol% ChgMkt Cap
GILDDown 2.41%167.37B
GSK108.37B
PFE186.99B
RHHBY249.58B

Key Statistics

Forward P/E (1 yr):11.47
P/S (ttm):9.84
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :8.05
Quarterly EPS Est (Sep-14) :1.92
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):0.58

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines for the treatment of life threatening diseases in North America, South America, Europe, and the Asia-Pacific. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback